MPM Capital and Qiming Venture Partners USA have co-led a series A round for Umoja Biopharma, based on research at Purdue University and Seattle Children’s Research Institute.

Zachary Ellis was the director of new ventures at Ohio State University for over three years but has left to join the institution’s long-time partner Rev1 Ventures.

Sean Mallon had left CIT in 2016 to become associate vice-president for entrepreneurship and innovation at George Mason University.

UCL and Francis Crick-founded Achilles has secured $69.9m in its series C round.

Europe-wide venture firm Speedinvest has now assembled $225m for its latest fund, also backed by Université PSL and targeting pre-seed and seed investments.

EPFL’s chip-link technology provider has added more than $36m to a Swisscom-backed round that now totals $92.3m, taking its total funding to almost $133m.

Berkeley Catalyst Fund-backed gene therapy developer 4D Molecular Therapeutics withdrew its last attempt in July.

Kevin Leslie, associate director of VCU Ventures, has moved on to become executive director of Hampton Roads Biomedical Research Consortium.

Polytechnic University of Valencia spinout VLC Photonics has been bought by Hitachi for an undisclosed sum nine years after it was founded.

Nereid Therapeutics will advance research by Clifford Brangwynne of Princeton University following its launch with a $50m series A round from Apple Tree Partners.